Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-034127
Filing Date
2015-04-14
Accepted
2015-04-14 19:48:33
Documents
2
Period of Report
2015-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3560
2 POA DOCUMENT poa.txt EX-24.3_576408 3066
  Complete submission text file 0001209191-15-034127.txt   8100
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6310 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Judice Kevin (Reporting) CIK: 0001638944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36912 | Film No.: 15770306